Beranda › Poliradikuloneuropati Demielinasi Inflamasi Kronis
Uji klinis Poliradikuloneuropati Demielinasi Inflamasi Kronis yang merekrut di AS
19 studi untuk Poliradikuloneuropati Demielinasi Inflamasi Kronis merekrut peserta di lokasi di seluruh Amerika Serikat.
Kota dengan studi terbanyak
- New York City, NY7 studi
- Miami, FL6 studi
- Houston, TX6 studi
- Kansas City, KS5 studi
- Philadelphia, PA5 studi
- Indio, CA5 studi
- New Haven, CT5 studi
- St. Louis, MO5 studi
- Tampa, FL4 studi
- Cleveland, OH4 studi
- Milwaukee, WI4 studi
- Washington, DC4 studi
- Birmingham, AL4 studi
- Orlando, FL4 studi
- San Francisco, CA4 studi
- Centennial, CO3 studi
- Austin, TX3 studi
- Cincinnati, OH3 studi
- Scottsdale, AZ3 studi
- Boston, MA3 studi
- Seattle, WA3 studi
- Portland, OR3 studi
Berdasarkan negara bagian
- Alabama4 studi
- Arizona4 studi
- California11 studi
- Colorado5 studi
- Connecticut6 studi
- Distrik Columbia4 studi
- Florida11 studi
- Illinois4 studi
- Kansas5 studi
- Louisiana3 studi
- Maryland3 studi
- Massachusetts4 studi
- Michigan5 studi
- Missouri5 studi
- New York8 studi
- North Carolina6 studi
- Ohio7 studi
- Oregon3 studi
- Pennsylvania6 studi
- Tennessee3 studi
- Texas10 studi
- Washington3 studi
- Wisconsin4 studi
Studi yang baru diperbarui
Teks studi resmi (Bahasa Inggris)
Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07032662Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Menerima pesertaFase 2/3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT05327114A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT07091630A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT06920004A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT06290141A Study Investigating Intravenous Human Normal Immune Globulin (IGIV) 10% KIg10 (QIVIGY) in Subjects With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 11 Sep 2026 · NCT06752356A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 9 Sep 2026 · NCT06680037A Study to Evaluate the Pharmacokinetics and Safety of XEMBIFY Versus Gamunex-C in Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 4 Sep 2026 · NCT07540221A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)
Menerima pesertaFase 3
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 2 Sep 2026 · NCT06858579A Study Evaluating the Safety and Efficacy of KITE-363 in Relapsed/Refractory Autoimmune Neurologic Diseases
Menerima pesertaFase 1
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 14 Agu 2026 · NCT07304154Real-world Study of Treatment Outcomes in Chronic Inflammatory Demyelinating Polyneuropathy/Polyradiculoneuropathy (CIDP)
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Jul 2026 · NCT06968975A Study of TAK-411 in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Apr 2026 · NCT06798012Real-World Efgartigimod Effectiveness in CIDP: A Prospective Study
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Apr 2026 · NCT07264426Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Mar 2026 · NCT07478172A Worldwide Pregnancy Safety Study to Assess Maternal, Fetal, and Infant Outcomes Following Exposure to Efgartigimod During Pregnancy and/or Breastfeeding.
Menerima pesertaStudi observasional
Semua usia · Wanita · Diperbarui 17 Feb 2026 · NCT06299748A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 20 Jan 2026 · NCT06747351IVIG vs SCIG in CIDP
Menerima pesertaFase 1
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 11 Des 2025 · NCT05584631A Study of HyQvia in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) in Routine Clinical Care
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 21 Nov 2025 · NCT06538064Biorepository and Registry for Plasma Exchange Patients
Menerima pesertaStudi observasional
Usia 12 hingga 99 · Semua jenis kelamin · Diperbarui 20 Mei 2025 · NCT05004493Dari ClinicalTrials.gov, data diambil 4 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.